Ilsung Pharmaceuticals Co., Ltd. (003120.KS)
KRW 15970.0
(-0.19%)
KRW 15970.0
(-0.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -39.71 Billion | -38.96 Billion | 5.7 Billion | 1.55 Billion | 4.38 Billion | 15.09 Billion |
| Net Income | -20.94 Billion | 105.24 Billion | -1.36 Billion | 3.22 Billion | 6.71 Billion | 2.94 Billion |
| Depreciation & Amortization | 2.84 Billion | 3.09 Billion | 3.07 Billion | 3.05 Billion | 3.08 Billion | 3.01 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -19.48 Billion | -44.57 Billion | 3.81 Billion | 2.45 Billion | 1.19 Billion | 9.56 Billion |
| Other non-cash items | -2.14 Billion | -102.72 Billion | 179.71 Million | -7.17 Billion | -6.61 Billion | -428.57 Million |
| Investing Cash Flow | -28.7 Billion | 266.82 Billion | 10.43 Billion | -1.11 Billion | -22.03 Billion | -14.83 Billion |
| Investments in PPE | -7.72 Billion | -62.49 Billion | -12.61 Billion | -4.81 Billion | -1.24 Billion | -1.33 Billion |
| Acquisitions | 474.37 Million | 122.06 Million | 9.2 Million | 6.17 Billion | 409.44 Million | 121.65 Million |
| Investment purchases | -115.42 Billion | -22.59 Billion | -4.71 Billion | -26.53 Billion | -60.49 Billion | -48.02 Billion |
| Sales/Maturities of investments | 73.33 Billion | 27.94 Billion | 25.99 Billion | 24.32 Billion | 39.29 Billion | 34.18 Billion |
| Other Investing Activities | 20.64 Billion | 323.85 Billion | 1.76 Billion | -263.71 Million | 150 Thousand | 209.48 Million |
| Financing Cash Flow | -44.52 Billion | -5.73 Billion | -1.48 Billion | -1.43 Billion | 14.73 Billion | -1 Billion |
| Debt repayment | -390.91 Million | - | -57.91 Million | - | - | - |
| Dividends payments | -29.65 Billion | -1.15 Billion | -1.15 Billion | -1.15 Billion | -1 Billion | -1 Billion |
| Common Stock Repurchased | -14.99 Billion | -4.22 Billion | - | - | - | - |
| Common Stock Issuance | -653.27 Million | - | - | - | 15.85 Billion | - |
| Other Financing Activities | 1.17 Billion | -357.22 Million | -273.06 Million | -285.49 Million | -117 Million | - |
| Accounts receivables | -7 Billion | -3.79 Billion | 619.95 Million | 2.12 Billion | 3.53 Billion | 6.55 Billion |
| Accounts payables | 684.31 Million | 4.38 Billion | -1.34 Billion | -225.3 Million | 31.05 Million | -2.95 Billion |
| Inventory | -11.41 Billion | -7.93 Billion | 1.75 Billion | 768.8 Million | -221.01 Million | 6.86 Billion |
| Other working capital | -1.74 Billion | -37.23 Billion | 2.78 Billion | -214.94 Million | -2.15 Billion | 2.69 Billion |
| Cash at beginning of period | 272.92 Billion | 50.84 Billion | 36.21 Billion | 37.27 Billion | 40.19 Billion | 2.14 Billion |
| Cash at end of period | 160.08 Billion | 272.92 Billion | 50.84 Billion | 36.21 Billion | 37.27 Billion | 1.39 Billion |
| Capital Expenditure | -7.72 Billion | -62.49 Billion | -12.61 Billion | -4.81 Billion | -1.24 Billion | -1.33 Billion |
| Effect of forex changes on cash | 109.12 Million | -47.52 Million | -31.45 Million | -63.48 Million | -1.97 Million | 3.9 Million |
| Net cash flow / Change in cash | -112.83 Billion | 222.07 Billion | 14.62 Billion | -1.05 Billion | -2.91 Billion | -752.68 Million |
| Free Cash Flow | -47.44 Billion | -101.46 Billion | -6.91 Billion | -3.26 Billion | 3.14 Billion | 13.76 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -421.8 Million | -666.64 Million | -20.94 Billion | -39.7 Billion | 4.48 Billion | -1.21 Billion |
| Depreciation & Amortization | 841.44 Million | 798.21 Million | 2.84 Billion | 352.28 Million | 902.22 Million | 929.41 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.36 Billion | 3.38 Billion | -19.48 Billion | -10.98 Billion | -6.33 Billion | -6.19 Billion |
| Other non-cash items | 7.94 Billion | -4.22 Billion | -2.14 Billion | 13.35 Billion | -6.75 Billion | -7.63 Billion |
| Investing Cash Flow | -121.45 Million | -31.91 Billion | -28.7 Billion | -25.23 Billion | 6 Billion | -2.85 Billion |
| Investments in PPE | -138.68 Million | -2.26 Billion | -7.72 Billion | -2.92 Billion | -2.6 Billion | -1.44 Billion |
| Acquisitions | -461.28 Million | 468.55 Million | 474.37 Million | 5 Million | 5.91 Billion | 2.23 Billion |
| Investment purchases | -105.02 Billion | -32.25 Billion | -115.42 Billion | -112.97 Billion | -215 Million | -2.23 Billion |
| Sales/Maturities of investments | 105.5 Billion | 2.12 Billion | 73.33 Billion | 70.68 Billion | 2.37 Billion | 70.6 Million |
| Other Investing Activities | 20.00 | 14 Million | 20.64 Billion | 19.97 Billion | 523.62 Million | -1.48 Billion |
| Financing Cash Flow | -10.23 Billion | -40.29 Million | -44.52 Billion | 347.87 Million | -44.84 Million | -40.16 Billion |
| Debt repayment | -36.26 Million | - | -390.91 Million | -390.91 Million | - | - |
| Dividends payments | -10.19 Billion | - | -29.65 Billion | - | - | -29.65 Billion |
| Common Stock Repurchased | - | - | -14.99 Billion | - | - | -10.42 Billion |
| Common Stock Issuance | - | - | -653.27 Million | - | - | - |
| Other Financing Activities | -36.26 Million | - | 1.17 Billion | 738.79 Million | - | -79.08 Million |
| Accounts receivables | 174.55 Million | 5.51 Billion | -7 Billion | -3.34 Billion | -897.31 Million | -1.98 Billion |
| Accounts payables | -3.64 Billion | 187.18 Million | 684.31 Million | -2.05 Billion | 414.25 Million | 2.77 Billion |
| Inventory | -677.55 Million | -646.01 Million | -11.41 Billion | 899.41 Million | -4.15 Billion | -6.97 Billion |
| Other working capital | 2.78 Billion | -1.67 Billion | -1.74 Billion | -6.47 Billion | -1.69 Billion | -15.52 Million |
| Cash at beginning of period | 131 Billion | 160.08 Billion | 272.92 Billion | 221.51 Billion | 223.38 Billion | 280.53 Billion |
| Cash at end of period | 121.95 Billion | 131 Billion | 160.08 Billion | 160.08 Billion | 221.51 Billion | 223.38 Billion |
| Capital Expenditure | -138.68 Million | -2.26 Billion | -7.72 Billion | -2.92 Billion | -2.6 Billion | -1.44 Billion |
| Effect of forex changes on cash | 145.52 Million | 119.14 Million | 109.12 Million | -1.71 Million | -119.87 Million | -15.93 Million |
| Net cash flow / Change in cash | -9.04 Billion | -29.08 Billion | -112.83 Billion | -61.43 Billion | -1.86 Billion | -57.15 Billion |
| Free Cash Flow | 1.02 Billion | 489.04 Million | -47.44 Billion | -39.9 Billion | -10.3 Billion | -15.56 Billion |
1452
1OJ
VEDL
4477
T1L
SPCG-R